BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Juillerat-Jeanneret L. The Other Angiotensin II Receptor: AT2R as a Therapeutic Target. J Med Chem 2020;63:1978-95. [PMID: 32030982 DOI: 10.1021/acs.jmedchem.9b01780] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Karimi F, Maleki M, Nematbakhsh M, Sun M. View of the Renin-Angiotensin System in Acute Kidney Injury Induced by Renal Ischemia-Reperfusion Injury. Journal of the Renin-Angiotensin-Aldosterone System 2022;2022:1-10. [DOI: 10.1155/2022/9800838] [Reference Citation Analysis]
2 Wang D, Zhao W, Zhang Z, Zhang Y, Li J, Huang W. Design, synthesis and biological evaluation of novel biphenylsulfonamide derivatives as selective AT2 receptor antagonists. Front Chem 2022;10:984717. [DOI: 10.3389/fchem.2022.984717] [Reference Citation Analysis]
3 Cong X, Zhang X, Liang X, He X, Tang Y, Zheng X, Lu S, Zhang J, Chen T. Delineating the conformational landscape and intrinsic properties of the angiotensin II type 2 receptor using a computational study. Comput Struct Biotechnol J 2022;20:2268-79. [PMID: 35615027 DOI: 10.1016/j.csbj.2022.05.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Urmila A, Rashmi P, Nilam G, Subhash B. Recent Advances in the Endogenous Brain Renin-Angiotensin System and Drugs Acting on It. J Renin Angiotensin Aldosterone Syst 2021;2021:9293553. [PMID: 34925551 DOI: 10.1155/2021/9293553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zeng Z, Ma C, Chen K, Jiang M, Vasu R, Liu R, Zhao Y, Zhang H. Roles of G Protein-Coupled Receptors (GPCRs) in Gastrointestinal Cancers: Focus on Sphingosine 1-Shosphate Receptors, Angiotensin II Receptors, and Estrogen-Related GPCRs. Cells 2021;10:2988. [PMID: 34831211 DOI: 10.3390/cells10112988] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Pucci F, Annoni F, Dos Santos RAS, Taccone FS, Rooman M. Quantifying Renin-Angiotensin-System Alterations in COVID-19. Cells 2021;10:2755. [PMID: 34685735 DOI: 10.3390/cells10102755] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
7 Aimo A, Vergaro G, Passino C, Clerico A. Evaluation of pathophysiological relationships between renin-angiotensin and ACE-ACE2 systems in cardiovascular disorders: from theory to routine clinical practice in patients with heart failure. Crit Rev Clin Lab Sci 2021;:1-16. [PMID: 34196254 DOI: 10.1080/10408363.2021.1942782] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Zhirnov VV, Velihina YS, Mitiukhin OP, Brovarets VS. Intrinsic drug potential of oxazolo[5,4-d]pyrimidines and oxazolo[4,5-d]pyrimidines. Chem Biol Drug Des 2021. [PMID: 34148293 DOI: 10.1111/cbdd.13911] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Guo Y, Huang X, Liao W, Meng L, Xu D, Ye C, Chen L, Hu T. Discovery and Optimization of Highly Potent and Selective AT2R Antagonists to Relieve Peripheral Neuropathic Pain. ACS Omega 2021;6:15412-20. [PMID: 34151119 DOI: 10.1021/acsomega.1c01866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Chen F, Gao W, Hu J, Yang X, Chai X, Wang D. Preoperative angiotensin II type 2 receptor is a predictor for developing chronic post-surgical pain after total knee arthroplasty surgery. Life Sci 2021;278:119654. [PMID: 34043993 DOI: 10.1016/j.lfs.2021.119654] [Reference Citation Analysis]
11 Tourwé D, Tsiailanis AD, Parisis N, Hirmiz B, Del Borgo M, Aguilar MI, Van der Poorten O, Ballet S, Widdop RE, Tzakos AG. Using conformational constraints at position 6 of Angiotensin II to generate compounds with enhanced AT2R selectivity and proteolytic stability. Bioorg Med Chem Lett 2021;43:128086. [PMID: 33965531 DOI: 10.1016/j.bmcl.2021.128086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Obeng S, Hiranita T, León F, McMahon LR, McCurdy CR. Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery. J Med Chem 2021;64:6523-48. [PMID: 33956427 DOI: 10.1021/acs.jmedchem.1c00028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 13.0] [Reference Citation Analysis]
13 Ranjit A, Khajehpour S, Aghazadeh-Habashi A. Update on Angiotensin II Subtype 2 Receptor: Focus on Peptide and Nonpeptide Agonists. Mol Pharmacol 2021;99:469-87. [PMID: 33795351 DOI: 10.1124/molpharm.121.000236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Flinn B, Royce N, Gress T, Chowdhury N, Santanam N. Dual role for angiotensin-converting enzyme 2 in Severe Acute Respiratory Syndrome Coronavirus 2 infection and cardiac fat. Obes Rev 2021;22:e13225. [PMID: 33660398 DOI: 10.1111/obr.13225] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Wannberg J, Gising J, Lindman J, Salander J, Gutiérrez-de-Terán H, Ablahad H, Hamid S, Grönbladh A, Spizzo I, Gaspari TA, Widdop RE, Hallberg A, Backlund M, Leśniak A, Hallberg M, Larhed M. N-(Methyloxycarbonyl)thiophene sulfonamides as high affinity AT2 receptor ligands. Bioorg Med Chem 2021;29:115859. [PMID: 33309749 DOI: 10.1016/j.bmc.2020.115859] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
16 Stein RA, Young LM. From ACE2 to COVID-19: A multiorgan endothelial disease. Int J Infect Dis 2020;100:425-30. [PMID: 32896660 DOI: 10.1016/j.ijid.2020.08.083] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
17 D'Ardes D, Boccatonda A, Rossi I, Guagnano MT, Santilli F, Cipollone F, Bucci M. COVID-19 and RAS: Unravelling an Unclear Relationship. Int J Mol Sci 2020;21:E3003. [PMID: 32344526 DOI: 10.3390/ijms21083003] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 26.5] [Reference Citation Analysis]
18 Vasile S, Hallberg A, Sallander J, Hallberg M, Åqvist J, Gutiérrez-de-Terán H. Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists. Biomolecules 2020;10:E649. [PMID: 32340100 DOI: 10.3390/biom10040649] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]